{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:10:08Z","timestamp":1740409808895,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10103001"],"award-info":[{"award-number":["2018ZX10103001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072245"],"award-info":[{"award-number":["82072245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.micpath.2025.107313","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T17:06:11Z","timestamp":1737392771000},"page":"107313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of IL-32 gene polymorphisms on tuberculosis susceptibility in a Chinese Han population"],"prefix":"10.1016","volume":"200","author":[{"given":"Li","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DaWen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiuLin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.micpath.2025.107313_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a Re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"year":"2024","series-title":"Global Tuberculosis Report 2024","author":"World Health","key":"10.1016\/j.micpath.2025.107313_bib2"},{"key":"10.1016\/j.micpath.2025.107313_bib3","series-title":"Tuberculosis","first-page":"233","author":"Bloom","year":"2017"},{"issue":"7034","key":"10.1016\/j.micpath.2025.107313_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/434709a","article-title":"Tuberculosis: the genetics of vulnerability","volume":"434","author":"Jabado","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.107313_bib5","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84394","article-title":"Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture","volume":"13","author":"Schurz","year":"2024","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.micpath.2025.107313_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4049\/jimmunol.1202802","article-title":"IL-32 promotes angiogenesis","volume":"192","author":"Nold-Petry","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107313_bib7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2337\/db19-0287","article-title":"Early detection of peripheral blood cell signature in children developing \u03b2-cell autoimmunity at a young age","volume":"68","author":"Kallionp\u00e4\u00e4","year":"2019","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.micpath.2025.107313_bib8","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2025.107313_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0083-6729(06)74008-0","article-title":"The newest interleukins: recent additions to the ever-growing cytokine family","volume":"74","author":"Chen","year":"2006","journal-title":"Vitam. Horm."},{"issue":"3","key":"10.1016\/j.micpath.2025.107313_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","article-title":"Molecular characterization of IL-32 in human endothelial cells","volume":"46","author":"Kobayashi","year":"2009","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.micpath.2025.107313_bib11","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.181.6.4010","article-title":"A human dendritic cell subset receptive to the Venezuelan equine encephalitis virus-derived replicon particle constitutively expresses IL-32","volume":"181","author":"Nishimoto","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2025.107313_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","article-title":"Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling","volume":"442","author":"Wen","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.micpath.2025.107313_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","article-title":"Molecular interactions and functions of IL-32","volume":"109","author":"Aass","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"16","key":"10.1016\/j.micpath.2025.107313_bib14","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.1424302112","article-title":"Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis","volume":"112","author":"Bai","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.micpath.2025.107313_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02553-21","article-title":"Interleukin 32 as a potential marker for diagnosis of tuberculous pleural effusion","volume":"10","author":"Du","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2025.107313_bib16","article-title":"Genetics and functional mechanisms of STAT3 polymorphisms in human tuberculosis","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107313_bib17","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1002\/jmv.27140","article-title":"Association of IL-32 rs28372698 polymorphism with active chronic HBV infection","volume":"93","author":"Zheng","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2025.107313_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2017.05.045","article-title":"Association between interleukin-32 polymorphism and multiple sclerosis","volume":"379","author":"Morsaljahan","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.micpath.2025.107313_bib19","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/cc10258","article-title":"Association between IL-32 genotypes and outcome in infection-associated acute lung injury","volume":"15","author":"Arcaroli","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.micpath.2025.107313_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep11063","article-title":"DNA methylation at IL32 in juvenile idiopathic arthritis","volume":"5","author":"Meyer","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107313_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep41629","article-title":"IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis","volume":"7","author":"Damen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107313_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1535194","article-title":"The biology and role of interleukin-32 in tuberculosis","volume":"2018","author":"Li","year":"2018","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.micpath.2025.107313_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/cr.2009.33","article-title":"A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis","volume":"19","author":"Li","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.micpath.2025.107313_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1081483","article-title":"Polymorphisms and gene expression of Notch4 in pulmonary tuberculosis","volume":"14","author":"Fang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.107313_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1063413","article-title":"Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters","volume":"13","author":"Annisa","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107313_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.5588\/ijtld.15.0450","article-title":"CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity","volume":"20","author":"Chen","year":"2016","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107313_bib27","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41598-019-40121-8","article-title":"Polymorphisms in CARD8 and NLRP3 are associated with extrapulmonary TB and poor clinical outcome in active TB in Ethiopia","volume":"9","author":"Abate","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.micpath.2025.107313_bib28","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.4049\/jimmunol.0901913","article-title":"IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages","volume":"184","author":"Bai","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2025.107313_bib29","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.micpath.2025.107313_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cyto.2015.06.013","article-title":"The role of interleukin-32 against tuberculosis","volume":"76","author":"Bai","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2025.107313_bib31","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.2147\/JIR.S379815","article-title":"Biomarkers in the pathogenesis, diagnosis, and treatment of systemic sclerosis","volume":"16","author":"Muruganandam","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.micpath.2025.107313_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1140373","article-title":"Interleukin-32 as a biomarker in rheumatic diseases: a narrative review","volume":"14","author":"Kwon","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107313_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1871530322666220512120948","article-title":"Increased salivary cytokines and nitric oxide levels in beh\u00e7et's disease: interleukin-32, a novel player in disease prognosis","volume":"23","author":"Hadjimi","year":"2023","journal-title":"Endocr., Metab. Immune Disord.: Drug Targets"},{"key":"10.1016\/j.micpath.2025.107313_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1264236","article-title":"IL-32 as a potential biomarker and therapeutic target in skin inflammation","volume":"14","author":"Wallimann","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.107313_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154832","article-title":"Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-\u03b1 and IL-6","volume":"125","author":"Fadaei","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2025.107313_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.969895","article-title":"Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing","volume":"13","author":"Varzari","year":"2022","journal-title":"Front. Genet."},{"issue":"7741","key":"10.1016\/j.micpath.2025.107313_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41586-018-0859-7","article-title":"Introns are mediators of cell response to starvation","volume":"565","author":"Parenteau","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micpath.2025.107313_bib38","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1038\/s41467-022-32887-9","article-title":"Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data","volume":"13","author":"Shiraishi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107313_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577820","article-title":"Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: correlation with NLRP3 inflammasome","volume":"365","author":"Hamzaoui","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107313_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051340","article-title":"Glutathione modulates efficacious changes in the immune response against tuberculosis","volume":"11","author":"Abnousian","year":"2023","journal-title":"Biomedicines"},{"issue":"50","key":"10.1016\/j.micpath.2025.107313_bib41","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/j.vaccine.2021.09.053","article-title":"Effects of Mycobacterium bovis Calmette et Gu\u00e9rin (BCG) in oncotherapy: Bladder cancer and beyond","volume":"39","author":"Mukherjee","year":"2021","journal-title":"Vaccine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T14:29:13Z","timestamp":1740407353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"alternative-id":["S0882401025000385"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107313","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of IL-32 gene polymorphisms on tuberculosis susceptibility in a Chinese Han population","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107313"}}